drugset / Trial / NCT00553605
Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double blind, double dummy, comparative, active-controlled trial designed to assess the analgesic activity and safety of intravenous doses of parecoxib 40 mg relative to intravenous doses of ketoprofen 100 mg for the treatment of renal colic in outpatients presenting at emergency room settings. This trial is designed to show non-inferiority of parecoxib related to ketoprofen.
Timeline
- Start
- 2007-06
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketoprofen | Small molecule | 100 mg | Intravenous |
| Comparator | Parecoxib | Small molecule | 40 mg | Intravenous |
Indications
No indication recorded.